Novavax Inc. Stock Slides 5.6%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Novavax Inc. slipped 5.6% to $9.30 on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 0.7% to 26,081.72 and Dow Jones Industrial Average falling 0.6% to 52,064.10.

This was the stock's fourth consecutive day of losses.

Novavax Inc. closed 22.3% below its 52-week high of $11.97, which the company reached on February 26th.

The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 0.3% to $266.35, Pfizer Inc. fell 0.5% to $27.65, and Merck & Co. Inc. fell 1.91% to $144.71.

Trading volume totaled 5.8 million, compared to the 50-day average of 4.2 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 10, 2026 16:34 ET (20:34 GMT)